Welcome to NerPharMa

 

NerPharMa operates as a Contract Development and Manufacturing Organization (CDMO) and is characterized by a strong specialization in oncology.

Operating since January 2010 as a part of NMS Group, is divided into two different units:

NerPharMa DP dealing with the development and manufacturing of finished dosage forms: injectables (solutions and lyophilized) and solid oral (tablets and capsules) for various therapeutic areas, not just oncological. Able to handle cytotoxic and cytostatic compounds and execute activities of formulation, packaging and clinical supply. NerPharMa DS is dedicated to development and production of active pharmaceutical ingredients for oncology (also cytotoxic/cytostatic), from laboratory scale to commercial production.

 

Meet us at...

CPhl Worldwide

24-26 October 2017

Messe Frankfurt, Germany